会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES
    • 采用膜表达人类表达和使用苯胺类改善ENaC增强剂在测定中使用膜电位报告染料的效果的改进的电生理学测定
    • WO2005014848A3
    • 2005-05-06
    • PCT/US2004021853
    • 2004-07-09
    • SENOMYX INCSERVANT GUYCHANG HONGREDCROW CYRILRAY SUMITACLARK IMRAN
    • SERVANT GUYCHANG HONGREDCROW CYRILRAY SUMITACLARK IMRAN
    • C07H21/04C07K1/00C12N1/20C12P21/06C12Q20060101G01N33/50G01N33/53G01N33/566G01N33/567G01N33/68
    • C12Q1/025C12N15/85C12N2320/10C12N2503/02G01N33/5044G01N33/6872G01N2500/10
    • In one aspect, the present invention relates to a mammalian cell-based high-throughput assay for the profiling and screening of human epithelial sodium channel (hENaC) cloned from a human kidney c-DNA library and is also expressed in other tissues including human taste tissue. The present invention further relates to amphibian oocyte-based medium-throughput electrophysiological assays for identifying human ENaC modulators, preferably ENaC enhancers. Compounds that modulate ENaC function in a cell-based ENaC assay are expected to affect salty taste in humans. The assays described herein have advantages over existing cellular expression systems. In the case of mammalian cells, such assays can be run in standard 96 or 384 well culture plates in high-throughput mode with enhanced assay results being achieved by the use of a compound that inhibits ENaC function, preferably an amiloride derivative such as Phenamil. In the case of the inventive oocyte electrophysiological assays (two-electrode voltage-clamp technique), these assays facilitate the identification of compounds which specifically modulate human ENaC. The assays of the invention provide a robust screen useful to detect compounds that facilitate (enhance) or inhibit hENaC function. Compounds that enhance or block human ENaC channel activity should thereby modulate salty taste in humans.
    • 一方面,本发明涉及用于分析和筛选从人肾c-DNA文库克隆的人上皮钠通道(hENaC)的基于哺乳动物细胞的高通量测定法,并且还在包括人味觉的其他组织中表达 组织。 本发明进一步涉及用于鉴定人ENaC调节剂,优选ENaC增强子的基于两栖动物卵母细胞的中等通量电生理测定。 预期在基于细胞的ENaC测定中调节ENaC功能的化合物会影响人类的咸味。 本文所述的测定相对于现有的细胞表达系统具有优势。 在哺乳动物细胞的情况下,这种测定可以在高通量模式下在标准96或384孔培养板中进行,通过使用抑制ENaC功能的化合物,优选阿米洛利衍生物如Phenamil实现增强的测定结果。 在本发明的卵母细胞电生理学测定法(双电极电压钳技术)的情况下,这些测定法有助于鉴定特异性调节人ENaC的化合物。 本发明的测定法提供了用于检测促进(增强)或抑制hENaC功能的化合物的强力筛选。 因此增强或阻断人类ENaC通道活性的化合物应该调节人类的咸味。
    • 2. 发明专利
    • BRPI0412471A
    • 2006-09-19
    • BRPI0412471
    • 2004-07-09
    • SENOMYX INC
    • SEVANT GUYCHANG HONGREDCROW CYRILSUMITA RAYCLARK IMRAN
    • C07H21/04C07K1/00C12N1/20C12P21/06C12Q20060101G01N33/50G01N33/53G01N33/566G01N33/567G01N33/68
    • In one aspect, the present invention relates to a mammalian cell-based high-throughput assay for the profiling and screening of human epithelial sodium channel (hENaC) cloned from a human kidney c-DNA library and is also expressed in other tissues including human taste tissue. The present invention further relates to amphibian oocyte-based medium-throughput electrophysiological assays for identifying human ENaC modulators, preferably ENaC enhancers. Compounds that modulate ENaC function in a cell-based ENaC assay are expected to affect salty taste in humans. The assays described herein have advantages over existing cellular expression systems. In the case of mammalian cells, such assays can be run in standard 96 or 384 well culture plates in high-throughput mode with enhanced assay results being achieved by the use of a compound that inhibits ENaC function, preferably an amiloride derivative such as Phenamil. In the case of the inventive oocyte electrophysiological assays (two-electrode voltage-clamp technique), these assays facilitate the identification of compounds which specifically modulate human ENaC. The assays of the invention provide a robust screen useful to detect compounds that facilitate (enhance) or inhibit hENaC function. Compounds that enhance or block human ENaC channel activity should thereby-modulate salty taste in humans.
    • 3. 发明专利
    • NO20060078L
    • 2006-04-07
    • NO20060078
    • 2006-01-05
    • SENOMYX INC
    • SERVANT GUYCHANG HONGREDCROW CYRILSUMITA RAYCLARK IMRAN
    • G01N33/48C07H21/04C07K1/00C12N1/20C12P21/06C12Q20060101G01N33/50G01N33/53G01N33/566G01N33/567G01N33/68
    • In one aspect, the present invention relates to a mammalian cell-based high-throughput assay for the profiling and screening of human epithelial sodium channel (hENaC) cloned from a human kidney c-DNA library and is also expressed in other tissues including human taste tissue. The present invention further relates to amphibian oocyte-based medium-throughput electrophysiological assays for identifying human ENaC modulators, preferably ENaC enhancers. Compounds that modulate ENaC function in a cell-based ENaC assay are expected to affect salty taste in humans. The assays described herein have advantages over existing cellular expression systems. In the case of mammalian cells, such assays can be run in standard 96 or 384 well culture plates in high-throughput mode with enhanced assay results being achieved by the use of a compound that inhibits ENaC function, preferably an amiloride derivative such as Phenamil. In the case of the inventive oocyte electrophysiological assays (two-electrode voltage-clamp technique), these assays facilitate the identification of compounds which specifically modulate human ENaC. The assays of the invention provide a robust screen useful to detect compounds that facilitate (enhance) or inhibit hENaC function. Compounds that enhance or block human ENaC channel activity should thereby-modulate salty taste in humans.